In regards to FTO in particular (but this logic also applies to other elements of RAC), I think what we haven't been told is just as important as what we have. Race obviously aren't in a position to release FTO data currently for all sorts of reasons that we can speculate on (IP protection, still gathering/analysing data, company strategy, etc.).
However, after studying Zantrene and FTO for so long now, including with human data obtained from Sheba, would Race be in a position to know that Zantrene actually doesn't inhibit FTO? This knowledge would likely at a minimum cause them to stop promoting Zantrene as a FIC/BIC FTO inhibitor, and probably would require an update to the market and change of company strategy/priorities given the material impact such a revelation would cause.
Thankfully, we've not seen or heard anything like this from the company. Instead, it's just radio silence.
General Comments / Chat, page-6891
-
- There are more pages in this discussion • 4,199 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M |
Open | High | Low | Value | Volume |
$1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9998 | $1.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9998 | 1.750 |
1 | 7599 | 1.730 |
1 | 581 | 1.720 |
3 | 11557 | 1.710 |
4 | 46280 | 1.700 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 2000 | 1 |
1.830 | 44030 | 2 |
1.840 | 10500 | 2 |
1.850 | 14500 | 3 |
1.860 | 949 | 2 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |